SCHEMBL23911441

SCHEMBL23911441

O=C(C1CN(C(=O)O)CC/C1=N/O)[C@H]1CCc2cc(Cl)cc(Br)c2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23911072 1.00
SCHEMBL23911074 1.00
SCHEMBL23910764 0.91 USP7 (0.32)
SCHEMBL23910767 0.91 USP7 (0.32)
SCHEMBL23910941 0.79 ESR2 (0.35)
SCHEMBL23921728 0.79 ESR2 (0.35)
SCHEMBL23911615 0.78 USP7 (0.36)
SCHEMBL23911618 0.78 USP7 (0.36)
SCHEMBL23910714 0.74 NFKB1 (0.39)
SCHEMBL23910670 0.74 NFKB1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317134-A1 UBIQUITIN-SPECIFIC-PROCESSING PROTEASE 7 (USP7) MODULATORS AND USES THEREOF RAPT THERAPEUTICS INC (US) 2021-10-14 US disclosed